Rana Mogannam Patient PAvilion (Booth #1029)

Rana was diagnosed with Stage IV metastatic breast cancer, HER2 triple positive at age 53. Started weekly treatment on IV Taxol for 16 weeks. IV Herceptin and Perjeta were also given every 3 weeks since the time of starting IV Taxol. After 3 years of IV therapy, transitioned to subcutaneous injections of Phesgo, a combination of Herceptin and Perjeta, administered every 3 weeks at UCSF – Rana will remain on this drug combination indefinitely.